Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Submitted by
admin
on May 27, 2009 - 7:38am
Source:
Seeking Alpha
News Tags:
Gilead Sciences
Amgen
Human Genome Sciences
Acorda Therapeutics
Biomarin
Amag Pharmaceuticals
Biogen Idec
Genzyme
Cougar Biotechnology
JNJ
OSI Pharmaceuticals
Cephalon
Allergan
Celgene
Myriad
Sequenom
Auxilium
Headline:
Q1 2009 Biotech Earnings Roundup: The Good, the Bad, and the Ugly
Do Not Allow Advertisers to Use My Personal information
